194 related articles for article (PubMed ID: 32100411)
1. Pharmacokinetic changes post-bariatric surgery: A scoping review.
McLachlan LA; Chaar BB; Um IS
Obes Rev; 2020 May; 21(5):e12988. PubMed ID: 32100411
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic effects of bariatric surgery.
Edwards A; Ensom MH
Ann Pharmacother; 2012 Jan; 46(1):130-6. PubMed ID: 22190251
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic considerations for patients with a history of bariatric surgery.
Lloret-Linares C
Expert Opin Drug Metab Toxicol; 2017 May; 13(5):493-496. PubMed ID: 28151695
[No Abstract] [Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
5. Fracture risk following bariatric surgery: a systematic review and meta-analysis.
Saad RK; Ghezzawi M; Habli D; Alami RS; Chakhtoura M
Osteoporos Int; 2022 Mar; 33(3):511-526. PubMed ID: 34988627
[TBL] [Abstract][Full Text] [Related]
6. Maternal and neonatal outcomes after bariatric surgery; a systematic review and meta-analysis: do the benefits outweigh the risks?
Kwong W; Tomlinson G; Feig DS
Am J Obstet Gynecol; 2018 Jun; 218(6):573-580. PubMed ID: 29454871
[TBL] [Abstract][Full Text] [Related]
7. Improved levothyroxine pharmacokinetics after bariatric surgery.
Gkotsina M; Michalaki M; Mamali I; Markantes G; Sakellaropoulos GC; Kalfarentzos F; Vagenakis AG; Markou KB
Thyroid; 2013 Apr; 23(4):414-9. PubMed ID: 23110329
[TBL] [Abstract][Full Text] [Related]
8. Lithium Intoxication after Bariatric Surgery: A Case Report.
Marques AR; Alho A; Martins JM; Bairrão M
Acta Med Port; 2021 May; 34(5):382-386. PubMed ID: 32955414
[TBL] [Abstract][Full Text] [Related]
9. Review article: The nutritional and pharmacological consequences of obesity surgery.
Stein J; Stier C; Raab H; Weiner R
Aliment Pharmacol Ther; 2014 Sep; 40(6):582-609. PubMed ID: 25078533
[TBL] [Abstract][Full Text] [Related]
10. The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review.
Angeles PC; Robertsen I; Seeberg LT; Krogstad V; Skattebu J; Sandbu R; Åsberg A; Hjelmesaeth J
Obes Rev; 2019 Sep; 20(9):1299-1311. PubMed ID: 31232513
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Bariatric Surgery and Gastrectomy on the Absorption of Drugs, Vitamins, and Mineral Elements.
Miedziaszczyk M; Ciabach P; Szałek E
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959391
[TBL] [Abstract][Full Text] [Related]
12. Influence of bariatric surgery on the use and pharmacokinetics of some major drug classes.
Yska JP; van der Linde S; Tapper VV; Apers JA; Emous M; Totté ER; Wilffert B; van Roon EN
Obes Surg; 2013 Jun; 23(6):819-25. PubMed ID: 23430479
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of drug absorption following bariatric surgery and its theoretical implications.
Padwal R; Brocks D; Sharma AM
Obes Rev; 2010 Jan; 11(1):41-50. PubMed ID: 19493300
[TBL] [Abstract][Full Text] [Related]
14. Impact of Roux-en-Y Gastric Bypass Surgery on Pharmacokinetics of Administered Drugs: Implications and Perspectives.
Srinivas NR
Am J Ther; 2016; 23(6):e1826-e1838. PubMed ID: 26398718
[TBL] [Abstract][Full Text] [Related]
15. Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors.
Lubrano C; Mariani S; Badiali M; Cuzzolaro M; Barbaro G; Migliaccio S; Genovesi G; Rossi F; Celanetti M; Fiore D; Pandolfo MM; Specchia P; Spera G
Int J Obes (Lond); 2010 Sep; 34(9):1404-14. PubMed ID: 20404828
[TBL] [Abstract][Full Text] [Related]
16. Oral Contraceptives after Bariatric Surgery.
Schlatter J
Obes Facts; 2017; 10(2):118-126. PubMed ID: 28433989
[TBL] [Abstract][Full Text] [Related]
17. [ADJUSTMENTS IN THE ORAL DRUG TREATMENT OF BARIATRIC PATIENTS].
Mahler I; Roder D
Harefuah; 2017 Jan; 156(1):29-30. PubMed ID: 28530311
[TBL] [Abstract][Full Text] [Related]
18. Altered drug disposition following bariatric surgery: a research challenge.
Greenblatt HK; Greenblatt DJ
Clin Pharmacokinet; 2015 Jun; 54(6):573-9. PubMed ID: 25782774
[TBL] [Abstract][Full Text] [Related]
19. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution.
Darwich AS; Pade D; Ammori BJ; Jamei M; Ashcroft DM; Rostami-Hodjegan A
J Pharm Pharmacol; 2012 Jul; 64(7):1008-24. PubMed ID: 22686346
[TBL] [Abstract][Full Text] [Related]
20. [Bariatric surgery, stomas and other digestive tract reductions: Insufficient data and recommendations to adapt medicines regimens in therapeutic practice].
Bernard É; Charpiat B; Mabrut JY; Dode X; Garcia S; Le Duff M; Rose FX; Ducerf C
Presse Med; 2015 Nov; 44(11):1162-8. PubMed ID: 26358672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
